Find clinical trials for Lymphoma in Sevilla, AN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Sevilla, AN, ESP:
This is a Phase I, open-label, multicenter study of HMPL-523 administered orally to patients with relapsed or refractory lymphoma who have e...
Phase 1
Seville, Spain and 31 other locations
on participants who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back af...
Phase 3
Seville, Spain and 98 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Seville, Spain and 59 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Sevilla, Spain and 59 other locations
The purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length...
Phase 3
Sevilla, Andaloucia, Spain and 34 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Sevilla, Spain and 73 other locations
This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.
Phase 2
Sevilla, Andalucia, Spain and 29 other locations
comprise 2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in patients with primary central nervous system lymphoma...
Phase 1, Phase 2
Sevilla, Spain and 29 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Sevilla, Spain and 142 other locations
dose escalation and expansion clinical trial to evaluate the safety, tolerability and PK of HMPL-689 in patients with relapsed or refractory lymphomas...
Phase 1
Seville, Spain and 26 other locations
Clinical trials
Research sites
Resources
Legal